OPK peer analysis
Opko Health (OPK) against its competitors: price, today's move, 1-year return and market value side by side.
OPK and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLLN BillionToOne | $111.00 | -2.54% | – | – |
| CSTL Castle Biosciences | $35.29 | -1.29% | 11.57% | $1.09B |
| FLGT Fulgent Genetics | $18.58 | -5.59% | -18.79% | $541.50M |
| GH Guardant Health | $137.35 | -18.53% | 39.95% | $22.62B |
| MDXH MDxHealth | $0.16 | -1.26% | -96.71% | – |
| MYGN Myriad Genetics | $6.29 | 4.57% | -2.55% | $575.81M |
| NEO NeoGenomics | $16.48 | -3.91% | 63.17% | $2.22B |
| NTRA Natera | $302.00 | -22.77% | 53.73% | $56.36B |
| PSNL Personalis | $15.54 | -1.58% | 78.01% | $1.69B |
| XGN Exagen | $7.60 | -10.69% | -29.43% | $206.16M |
| OPK Opko Health | $1.72 | -2.82% | 23.74% | $1.32B |
- OPK's peers: BLLN (BillionToOne), CSTL (Castle Biosciences), FLGT (Fulgent Genetics), GH (Guardant Health), MDXH (MDxHealth), MYGN (Myriad Genetics), NEO (NeoGenomics), NTRA (Natera).
Updated 2026-11-06 07:48 UTC